Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.25.0.1
Stock-based Compensation (Tables)
3 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Restricted Stock Awards (“RSAs”)
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 17,500 $ 37.82 
Outstanding at December 31, 2024 (a) 17,500 $ 37.82 
a.The weighted average remaining contractual term is 0.5 years and the aggregate intrinsic value of RSAs expected to vest is $454.
There was $94 and $150 of total unrecognized stock compensation costs related to unvested stock compensation for the RSAs at December 31, 2024 and September 30, 2024, respectively.
Stock Option Grants
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(years)
Aggregate
Intrinsic
Value
Vested and outstanding - December 31, 2024 38,000 $ 33.75  2.0
On December 23, 2024, the Company granted MRSUs to one of its executives, which will be eligible to be earned if at any time prior to September 30 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth in below:

Price Per Share Threshold
Number of MRSUs Earned
$35 per share
5,000
$40 per share
12,500
$45 per share
20,500
The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs are as follows:

Three months ended
December 31, 2024
Expected volatility of stock price 33.14  %
Risk-free interest rate 4.26  %
Expected term of awards (years) 2.77
Dividend yield 0.76  %
Grant date stock price $ 26.15 
Market-based Restricted Stock Units Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 —  $ — 
Granted 38,000 $ 12.32 
Vested —  $ — 
Forfeited —  $ — 
Outstanding at December 31, 2024 (a) 38,000 $ 12.32 
a.The weighted average remaining contractual term is 2.8 years and the aggregate intrinsic value of MRSUs expected to vest is $985.